Moisturizers for Aging
(BIA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how two popular moisturizers, Vaseline and CeraVe, might reduce signs of skin inflammation in older adults with dry skin. Researchers aim to determine if these moisturizers can improve the skin’s barrier and reduce inflammation in the body. Participants will use one of the moisturizers for four weeks, then pause use to observe changes in skin and inflammation levels. This trial targets individuals aged 70 and older with dry skin on areas such as the arms, legs, and torso. As a Phase 4 trial, it involves FDA-approved treatments and seeks to understand their benefits for a broader patient population.
Will I have to stop taking my current medications?
Yes, if you are currently using topical medications, oral systemic immunomodulatory treatments, or anti-microbial treatments, you will need to stop taking them to participate in this trial.
What is the safety track record for these treatments?
Research has shown that both CeraVe Moisturizing Cream and Vaseline are generally safe for skin use. Studies have found that CeraVe, which contains ceramides and hyaluronic acid, helps keep skin hydrated without causing irritation. However, a few individuals might experience allergic reactions to certain ingredients.
Vaseline, made from white petroleum jelly, soothes and protects most skin types. It is usually well tolerated, but those with allergies or sensitive skin should exercise caution. Overall, both products are widely used and available without a prescription, indicating they are generally safe for everyday use.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about these treatments because CeraVe Moisturizing Cream and Vaseline offer unique benefits for aging skin. CeraVe stands out due to its inclusion of ceramides and hyaluronic acid, both of which are crucial for retaining skin moisture and improving the skin barrier, unlike many standard moisturizers. Vaseline, on the other hand, is known for its occlusive properties, effectively locking in moisture to protect the skin, which is different from many lighter moisturizers. These distinct mechanisms provide promising options for enhancing skin health as we age.
What evidence suggests that this trial's moisturizers could be effective for aging skin?
This trial will compare the effectiveness of CeraVe Moisturizing Cream and Vaseline in improving skin hydration and protection. Research has shown that CeraVe, which contains ceramides, can boost skin moisture and reduce dry skin symptoms, locking in moisture and reducing itchiness and dryness for up to 72 hours. Participants in this trial may receive CeraVe as part of their treatment. Vaseline, known for forming a barrier on the skin's surface, prevents water loss and supports skin health by creating a protective seal. Participants may also receive Vaseline as part of their treatment. Both treatments have shown promising results in soothing dry skin and promoting skin health.678910
Who Is on the Research Team?
Katrina Abuabara, MD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for older adults with dry skin who are interested in how moisturizers like CeraVe and Vaseline might affect their skin's barrier function and inflammation levels. Participants should be willing to apply these products daily for 4 weeks and undergo testing. Specific eligibility criteria details were not provided.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants apply one of two topical moisturizers (Vaseline or CeraVe) once daily for 4 weeks, followed by a 4-week period without moisturizer
Follow-up
Participants are monitored for changes in skin barrier function, skin microbiome, and serum inflammatory markers
What Are the Treatments Tested in This Trial?
Interventions
- CeraVe Moisturizing Cream
- Vaseline
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator